Literature DB >> 3134391

Induction of ovulation with pulsatile GnRH in hypothalamic amenorrhoea.

A Gompel1, P Mauvais-Jarvis.   

Abstract

Pulsatile administration of gonadotrophin releasing hormone (GnRH) is a very effective treatment for induction of ovulation in hypothalamic amenorrhoea (HA). Thirty-seven women have been treated for a total of 117 cycles which resulted in 42 pregnancies--four treatment failures occurred. If these cycles are excluded, the 42 pregnancies were obtained within 2.3 cycles. One twin pregnancy occurred and no hyperstimulation was observed. The treatment was administered intravenously with a dosage schedule based on the grading of HA. We concluded that pulsatile GnRH was safe and very successful in induction of pregnancy in HA. Other indications (polycystic ovary syndrome and luteal phase defect) remain much less suitable for this treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134391     DOI: 10.1093/oxfordjournals.humrep.a136731

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  4 in total

Review 1.  [Pulsatile therapy with LHRH].

Authors:  M H Birkhäuser
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review.

Authors:  Bernd Th Krause; Ralf Ohlinger; Annette Haase
Journal:  Biologics       Date:  2009-07-13

3.  Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?

Authors:  Agathe Dumont; Didier Dewailly; Pauline Plouvier; Sophie Catteau-Jonard; Geoffroy Robin
Journal:  Reprod Biol Endocrinol       Date:  2016-04-29       Impact factor: 5.211

4.  Where Have the Periods Gone? The Evaluation and Management of Functional Hypothalamic Amenorrhea

Authors:  Marie Eve Sophie Gibson; Nathalie Fleming; Caroline Zuijdwijk; Tania Dumont
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-02-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.